J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 52(11); 2009 > Article
Lee and Kim: Nonpharmacological Interventions for Alzheimer's Disease

Abstract

Although acetylcholinesterase inhibitors (e.g., tacrine, donepezil, rivastigmine, and galantamine) and NMDA receptor antagonists (e.g., memantin) have demonstrated efficacy in the temporal symptomatic control of cognitive decline and daily function in Alzheimer's disease (AD) patients, their effect is not good enough to restore premorbid function, nor is it maintained in the later stages. Therefore, nonpharmacological interventions are being increasingly advocated in order to optimize the cognition, affect and global functioning of AD patients. We reviewed the current nonpharmacological interventions for AD. Nonpharmacological interventions can be divided into two groups. One is cognitive interventions (e.g., Memory rehabilitations, Reality orientation, Reminiscence therapy and so on) and the other is behavioral interventions (e.g., unmet needs interventions, learning and behavioral interventions, environmental vulnerability and reduced stress-threshold interventions). Cognitive interventions are aimed to slow and compensate cognitive decline of AD patients. On the other hand, behavioral interventions are aimed to reduce neuropsychiatric symptoms (depression, anxiety, agitation, wandering, aggression and so on) of AD patients. Although many of the nonpharmacological interventions have proven beneficial for AD patients, their efficacy was still ambiguous. Randomized and controlled study with a larger sample size is needed to confirm efficacy of nonpharmacological interventions.

References

1. Vance DE, Moore BS, Farr KF, Struzick T. Procedural memory and emotional attachment in Alzheimer disease: implications for meaningful and engaging activities. J Neurosci Nurs 2008;40:96-102.

2. Yesavage JA, Westphal J, Rush L. Senile dementia: combined pharmacologic and psychologic treatment. J Am Geriatr Soc 1981;29:164-171.

3. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K. Longterm effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia 1994;5:88-98.

4. Rothi LJ, Fuller R, Leon SA, Kendall D, Moore A, Wu SS, Crosson B, Heilman KM, Nadeau SE. Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease. J Int Neuropsychol Soc 2009;15:311-322.

5. Clare L, Wilson BA, Carter G, Breen K, Gosses A, Hodges JR. Intervening with everyday memory problems in dementia of Alzheimer type: an errorless learning approach. J Clin Exp Neuropsychol 2000;22:132-146.

6. Kixmiller JS. Evaluation of prospective memory training for individuals with mild Alzheimer's disease. Brain Cogn 2002;49:237-241.

7. Provencher V, Bier N, Audet T, Gagnon L. Errorless-based techniques can improve route finding in early Alzheimer's disease: a case study. Am J Alzheimers Dis Other Demen 2008;23:47-56.

8. Ruis C, Kessels RP. Effects of errorless and errorful face-name associative learning in moderate to severe dementia. Aging Clin Exp Res 2005;17:514-517.

9. Metzler-Baddeley C, Snowden JS. Brief report: errorless versus errorful learning as a memory rehabilitation approach in Alzheimer's Disease. J Clin Exp Neuropsychol 2005;27:1070-1079.

10. Glisky EL, Schacter DL, Tulving E. Learning and retention of computer-related vocabulary in memory-impaired patients: method of vanishing cues. J Clin Exp Neuropsychol 1986;8:292-312.

11. Glisky E, Schacter DL. Acquisition of domain-specific knowledge in patients with organic memory disorders. J Learn Disabil 1988;21:333-339. 351.

12. Diesfeldt HF, Smits JC. Faces get names-cognitive training for psychogeriatric patients for remembering names and faces. Tijdschr Gerontol Geriatr 1991;22:221-227.

13. Thoene AI, Glisky EL. Learning of name-face associations in memory impaired patients: a comparison of different training procedures. J Int Neuropsychol Soc 1995;1:29-38.

14. Graf P, Schacter DL. Implicit and explicit memory for new associations in normal and amnesic subjects. J Exp Psychol Learn Mem Cogn 1985;11:501-518.

15. Kessels RP, de Haan EH. Implicit learning in memory rehabilitation: a meta-analysis on errorless learning and vanishing cues methods. J Clin Exp Neuropsychol 2003;25:805-814.

16. McKitrick LA, Camp CJ, Black FW. Prospective memory intervention in Alzheimer's disease. J Gerontol 1992;47:337-343.

17. Abrahams JP, Camp CJ. Maintenance and generalisation of object naming training in anomia associated with degenerative dementia. Clin Gerontologist 1993;12:57-72.

18. Bier N, Van Der Linden M, Gagnon L, Desrosiers J, Adam S, Louveaux S, Saint-Mleux J. Face-name association learning in early Alzheimer's disease: a comparison of learning methods and their underlying mechanisms. Neuropsychol Rehabil 2008;18:343-371.

19. Camp CJ, Stevens AB. Spaced retrieval: a memory intervention for dementia of the Alzheimer's type (AD). Clin Gerontologist 1990;10:58-61.

20. Hochhalter AK, Overmier JB, Gasper SM, Bakke BL, Holub RJ. A comparison of spaced retrieval to other schedules of practice for people with dementia. Exp Aging Res 2005;31:101-118.

21. Lee SB, Park CS, Jeong JW, Choe JY, Hwang YJ, Park CA, Park JH, Lee DY, Jhoo JH, Kim KW. Effects of spaced retrieval training (SRT) on cognitive function in Alzheimer's disease (AD) patients. Arch Gerontol Geriatr 2009;49:289-293.

22. Hart T, Hawkey K, Whyte J. Use of a portable voice organizer to remember therapy goals in traumatic brain injury rehabilitation: a within-subjects trial. J Head Trauma Rehabil 2002;17:556-570.

23. van den Broek MD, Downes J, Johnson Z, Dayus B, Hilton N. Evaluation of an electronic memory aid in the neuro-psychological rehabilitation of prospective memory deficits. Brain Inj 2000;14:455-462.

24. Wilson BA, Evans JJ, Emslie H, Malinek V. Evaluation of NeuroPage: a new memory aid. J Neurol Neurosurg Psychiatry 1997;63:113-115.

25. Evans JJ, Emslie H, Wilson BA. External cueing systems in the rehabilitation of executive impairments of action. J Int Neuropsychol Soc 1998;4:399-408.

26. Teasdale TW, Emslie H, Quirk K, Evans J, Fish J, Wilson BA. Alleviation of carer strain during the use of the NeuroPage device by people with acquired brain injury. J Neurol Neurosurg Psychiatry 2009;80:781-783.

27. Wilson BA, Scott H, Evans J, Emslie H. Preliminary report of a NeuroPage service within a health care system. Neuro Rehabilitation 2003;18:3-8.

28. Baldelli MV, Pirani A, Motta M, Abati E, Mariani E, Manzi V. Effects of reality orientation therapy on elderly patients in the community. Arch Gerontol Geriatr 1993;17:211-218.

29. Spector A, Orrell M, Davies S, Woods B. Reality orientation for dementia. Cochrane Database Syst Rev 2000;CD001119.

30. O'Donovan S. The memory lingers on. Nurs Elder 1993;5:27-31.

31. Spector A, Orrell M, Davies S, Woods RT. Reminiscence therapy for dementia. Cochrane Database Syst Rev 2000;CD001120.

32. Woods B, Spector A, Jones C, Orrell M, Davies S. Reminiscence therapy for dementia. Cochrane Database Syst Rev 2005;CD001120.

33. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, Warren A. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997;9:556-561.

34. Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 1997;277:806-812.

35. Yaffe K, Fox P, Newcomer R, Sands L, Lindquist K, Dane K, Covinsky KE. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002;287:2090-2097.

36. Briesacher BA, Limcangco MR, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, Stuart B. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005;165:1280-1285.

37. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608.

38. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-1943.

39. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005;353:2335-2341.

40. Ayalon L, Gum AM, Feliciano L, Arean PA. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 2006;166:2182-2188.

41. Palmer CV, Adams SW, Bourgeois M, Durrant J, Rossi M. Reduction in caregiver-identified problem behaviors in patients with Alzheimer disease post-hearing-aid fitting. J Speech Lang Hear Res 1999;42:312-328.

42. Snyder M, Egan EC, Burns KR. Efficacy of hand massage in decreasing agitation behaviors associated with care activities in persons with dementia. Geriatr Nurs 1995;16:60-63.

43. Feil NW. Group therapy in a home for the aged. Gerontologist 1967;7:192-195.

44. Hitch S. Cognitive therapy as a tool for caring for the elderly confused person. J Clin Nurs 1994;3:49-55.

45. Neal M, Briggs M. Validation therapy for dementia. Cochrane Database Syst Rev 2003;CD001394.

46. Kragt K, Holtkamp CC, van Dongen MC, van Rossum E, Salentijn C. The effect of sensory stimulation in the sensory stimulation room on the well-being of demented elderly. A cross-over trial in residents of the R.C. Care Center Bernardus in Amsterdam. Verpleegkunde 1997;12:227-236.

47. Holtkamp CC, Kragt K, van Dongen MC, van Rossum E, Salentijn C. Effect of snoezelen on the behaviour of demented elderly. Tijdschr Gerontol Geriatr 1997;28:124-128.

48. Hope KW. The effects of multisensory environments on older people with dementia. J Psychiatr Ment Health Nurs 1998;5:377-385.

49. Hope K. Using multi-sensory environments with older people with dementia. J Adv Nurs 1997;25:780-785.

50. Baker R, Holloway J, Holtkamp CC, Larsson A, Hartman LC, Pearce R, Scherman B, Johansson S, Thomas PW, Wareing LA, Owens M. Effects of multi-sensory stimulation for people with dementia. J Adv Nurs 2003;43:465-477.

51. Guetin S, Portet F, Picot MC, Pommie C, Messaoudi M, Djabelkir L, Olsen AL, Cano MM, Lecourt E, Touchon J. Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study. Dement Geriatr Cogn Disord 2009;28:36-46.

52. Gerdner LA, Swanson EA. Effects of individualized music on confused and agitated elderly patients. Arch Psychiatr Nurs 1993;7:284-291.

53. Ragneskog H, Asplund K, Kihlgren M, Norberg A. Individualized music played for agitated patients with dementia: analysis of video-recorded sessions. Int J Nurs Pract 2001;7:146-155.

54. Cohen-Mansfield J, Werner P. Management of verbally disruptive behaviors in nursing home residents. J Gerontol A Biol Sci Med Sci 1997;52:M369-M377.

55. Clark ME, Lipe AW, Bilbrey M. Use of music to decrease aggressive behaviors in people with dementia. J Gerontol Nurs 1998;24:10-17.

56. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002;63:553-558.

57. Snow LA, Hovanec L, Brandt J. A controlled trial of aromatherapy for agitation in nursing home patients with dementia. J Altern Complement Med 2004;10:431-437.

58. Lin PW, Chan WC, Ng BF, Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomized trial. Int J Geriatr Psychiatry 2007;22:405-410.

59. Lee SY. The effect of lavender aromatherapy on cognitive function, emotion, and aggressive behavior of elderly with dementia. Taehan Kanho Hakhoe Chi 2005;35:303-312.

60. MacMahon S, Kermode S. A clinical trial of the effect of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. Aust J Holist Nurs 1998;5:47-49.

61. Nguyen QA, Paton C. The use of aromatherapy to treat behavioural problems in dementia. Int J Geriatr Psychiatry 2008;23:337-346.

62. Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges. Am J Alzheimers Dis Other Demen 2002;17:169-174.

63. Bakke BL, Kvale S, Burns T, McCarten JR, Wilson L, Maddox M, Cleary J. Multicomponent intervention for agitated behavior in a person with Alzheimer's disease. J Appl Behav Anal 1994;27:175-176.

64. Feliciano L, Vore J, LeBlanc LA, Baker JC. Decreasing entry into a restricted area using a visual barrier. J Appl Behav Anal 2004;37:107-110.

65. Heard K, Watson TS. Reducing wandering by persons with dementia using differential reinforcement. J Appl Behav Anal 1999;32:381-384.

66. Moniz-Cook E, Woods RT, Richards K. Functional analysis of challenging behaviour in dementia: the role of superstition. Int J Geriatr Psychiatry 2001;16:45-56.

67. Lovell BB, Ancoli-Israel S, Gevirtz R. Effect of bright light treatment on agitated behavior in institutionalized elderly subjects. Psychiatry Res 1995;57:7-12.



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next